Study Phase | Phase’s title | Objectives | Activities | Outputs | Timeline |
---|---|---|---|---|---|
I | Building coalition | To engage all stakeholders and key actors for successful program implementation | 1. FGDs 2. IDIs 3. Informal discussion | A joint agreement and statement of key actors to participate in the program implementation | February-March 2025 |
II | Program development | 1. To adapt the theoretical conceptual model of the program into the local context 2. To mitigate potential barriers in the program implementation; and 3. To develop intervention packages for the successful implementation of the program. | 1. Literature Review 2. IDIs 3. FGDs | 1. An adapted conceptual model for program implementation 2. Program guidance, training material and practice aids for the program implementation | April-May 2025 |
III | Socialization and capacity building | 1. To socialize the program concept and its instrument aids to the key actors and implementers. 2. To improve the capacity of the implementers for program implementation. 3. To receive a strong commitment from the implementers for the study’s implementation. | A two-day certified workshop | 1. Improving the capacity of implementers on knowledge and skills related to TB case detection 2. A joint agreement and statement of the implementer to participate in the program implementation | June-August 2025 |
IV | Implementation and Evaluation | 1. To implement the developed program 2. To evaluate the developed program | 1. A three-month program implementation 2. Program monitoring and supervision 3. FGD | 1. Effectiveness of the program, i.e., (1) the number of pharmacy visitors who receive TB screening by pharmacy personnel; (2) the number of pharmacy visitors with presumed TB referred to the CHC; (3) the number of pharmacy visitors who receive TB examination; and (4) the number of pharmacy visitors who are TB positive 2. Implementation program, i.e., key factors of success in the program implementation | September-November 2025 |